Nanoscale tech tracks proteins inside living neurons to guide Alzheimer's and Parkinson's drug discovery
A technology developed at The University of Queensland allowing scientists to observe how disease-related proteins behave inside living neurons will be used to advance early drug discovery for neurodegenerative diseases.
A technology developed at The University of Queensland allowing scientists to observe how disease-related proteins behave inside living neurons will be used to advance early drug discovery for neurodegenerative diseases.
The short version
- This article has been reviewed according to Science X's editorial process and policies .
- The platform is the result of more than two decades of research at UQ's Queensland Brain Institute (QBI), led by professor Frederic Meunier.
- Meunier said NASTIC emerged from a fundamental scientific question about how proteins behave in living brain cells.
What happened
"NASTIC allows us to track how key proteins move, cluster and interact inside living neurons and observe how potential drug candidates influence those behaviors," Meunier said. "It provides an unprecedented view of what happens as diseases such as Alzheimer's and Parkinson's progress.
Why it matters
Phys.org says nanoscale tech tracks proteins inside living neurons to guide alzheimer's and parkinson's drug discovery is the central development readers should understand.
Summary by Nerd News Network. Read the full article at Phys.org via the links above and below.